May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Effect of Gatifloxacin 0.3% and Moxifloxacin 0.5% on Corneal Epithelial Wound Healing After Photorefractive Keratectomy
Author Affiliations & Notes
  • R. Solomon
    Ophthalmic Consultants of Long Island, Rockville Centre, NY
  • E.D. Donnenfeld
    Ophthalmic Consultants of Long Island, Rockville Centre, NY
  • H.D. Perry
    Ophthalmic Consultants of Long Island, Rockville Centre, NY
  • J.R. Wittpenn
    Ophthalmic Consultants of Long Island, Rockville Centre, NY
  • H. Greenman
    Ophthalmic Consultants of Long Island, Rockville Centre, NY
  • J. Stein
    Ophthalmic Consultants of Long Island, Rockville Centre, NY
  • Footnotes
    Commercial Relationships  R. Solomon, None; E.D. Donnenfeld, Allergan, Inc C; H.D. Perry, Allergan, Inc. C; J.R. Wittpenn, Allergan, Inc. C; H. Greenman, None; J. Stein, None.
  • Footnotes
    Support  Allergan
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4895. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. Solomon, E.D. Donnenfeld, H.D. Perry, J.R. Wittpenn, H. Greenman, J. Stein; Effect of Gatifloxacin 0.3% and Moxifloxacin 0.5% on Corneal Epithelial Wound Healing After Photorefractive Keratectomy . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4895. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the effects of commercially available gatifloxacin (Zymar®) and moxifloxacin (VigamoxTM) on epithelial wound healing following photorefractive keratectomy (PRK). Methods: Twenty–two patients undergoing bilateral PRK were randomized in a double–masked study to receive gatifloxacin or moxifloxacin one day prior to surgery and postoperatively for one week. The size of the epithelial defects was recorded at the time of surgery and then daily until the defects healed. Digital photography was performed daily until the epithelial defects closed. Uncorrected visual acuity was recorded at all visits. Best–corrected visual acuity and corneal clarity were recorded at all visits following 1 week. Results: Mean epithelial closure time for gatifloxacin–treated eyes was significantly faster at 3.8 +/– 0.61 days (range 3 – 5 days) than for the moxifloxacin–treated eyes, 4.7 +/– 1.21 days (range 3 – 7 days) (p = 0.002). One eye treated with moxifloxacin exhibited corneal haze. All eyes other than the one that developed cornea haze demonstrated a BCVA of at least 20/20 at six months. Conclusions: Moxifloxacin delays corneal epithelial wound healing in comparison to gatifloxacin in patients undergoing PRK.

Keywords: refractive surgery: PRK • antibiotics/antifungals/antiparasitics • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×